An exploratory analysis of the association between EORTC QLQ-C30 domains and the progression-free/overall survival in advanced melanoma after 12 weeks of treatment on ipilimumab compared to gp100 in a phase III clinical trial

Authors:

Lee D, Harvey B, Gaudin A-F, Gueron B, Bregman B, Lebbé C, Bonnetain F, Borget I.

Publication Type:

Conference Proceedings – Poster

Publication Name:

16th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Lee D, Harvey B, Gaudin A-F, Gueron B, Bregman B, Lebbé C, Bonnetain F and Borget I. An exploratory analysis of the association between EORTC QLQ-C30 domains and the progression-free/overall survival in advanced melanoma after 12 weeks of treatment on ipilimumab compared to gp100 in a phase III clinical trial. 16th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Dublin, Ireland. 2-6 November. Poster PCN170.


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies